← All ABPATH Flashcard Decks

Blood Banking and Transfusion Flashcards

6 cards from real ABPATH practice questions. Tap to flip, then mark Knew It or Still Learning — missed cards come back until you master them.

Read the first 6 Blood Banking and Transfusion flashcards as text
  1. A 68-year-old male with a history of myelodysplastic syndrome receives a transfusion of 2 units of packed red blood cells. Five days later, he presents with a low-grade fever, mild jaundice, and a greater than expected drop in his hemoglobin level. A direct antiglobulin test (DAT) is now positive. Which of the following is the most likely cause of this presentation?

    Answer: Delayed hemolytic transfusion reaction

    The patient's presentation of symptoms such as fever and jaundice several days after a transfusion, along with a positive DAT and unexpected anemia, is characteristic of a delayed hemolytic transfusion reaction (DHTR). [8, 15] This reaction occurs when a patient has been previously sensitized to a red blood cell antigen and has an anamnestic antibody response upon re-exposure through transfusion. [26] Acute reactions occur within 24 hours, TA-GVHD has different primary symptoms, and febrile reactions typically do not involve hemolysis or a positive DAT.

  2. A blood bank technologist is resolving an ABO discrepancy. The forward typing shows A positive, while the reverse typing is consistent with group O (anti-A and anti-B are reactive). The patient is a 75-year-old male with multiple myeloma. What is the most likely cause of this discrepancy?

    Answer: Rouleaux formation

    The discrepancy described (forward type A, reverse type O) is a classic example of a Group III ABO discrepancy. [2] In patients with conditions causing hyperproteinemia, such as multiple myeloma, red blood cells can non-specifically aggregate in a 'stack of coins' appearance known as rouleaux formation. [14] This can cause false agglutination in the forward typing. Saline replacement or dilution techniques can typically resolve this type of discrepancy. [14]

  3. Which of the following is the primary reason for irradiating cellular blood components?

    Answer: To prevent transfusion-associated graft-versus-host disease (TA-GVHD)

    The sole purpose of irradiating cellular blood products is to inactivate donor T-lymphocytes, thereby preventing their proliferation and engraftment in a susceptible recipient. [19, 36, 38] This action prevents transfusion-associated graft-versus-host disease (TA-GVHD), a rare but highly fatal complication of transfusion. [36, 39] Irradiation does not eliminate bacteria or viruses.

  4. A patient with disseminated intravascular coagulation (DIC) and significant hypofibrinogenemia requires factor replacement. Which blood component is the most concentrated source of fibrinogen?

    Answer: Cryoprecipitate

    Cryoprecipitate is a plasma-derived product that is prepared by thawing Fresh Frozen Plasma and collecting the cold-insoluble precipitate. [5, 13] This process concentrates several clotting factors, most notably fibrinogen, as well as Factor VIII, Factor XIII, and von Willebrand factor. [10, 37] It is the most concentrated source of fibrinogen available for transfusion. [10]

  5. A patient develops acute respiratory distress, hypoxemia, and bilateral pulmonary infiltrates on chest X-ray within 2 hours of receiving a platelet transfusion. There are no signs of circulatory overload. Which of the following is the most likely diagnosis?

    Answer: Transfusion-Related Acute Lung Injury (TRALI)

    The clinical presentation of acute respiratory distress, non-cardiogenic pulmonary edema, and hypoxemia occurring within 6 hours of a transfusion is the classic definition of Transfusion-Related Acute Lung Injury (TRALI). [4, 18, 35] It is a leading cause of transfusion-related mortality. [4] The absence of signs of heart failure or volume overload helps distinguish it from TACO. [28]

  6. Which of the following infectious agents is NOT universally tested for on all allogeneic blood donations in the United States?

    Answer: Cytomegalovirus (CMV)

    While all blood donations in the U.S. are tested for a panel of infectious agents including HIV, HCV, HBV, and others, Cytomegalovirus (CMV) testing is not performed on every unit. [9, 12, 23] CMV testing is typically performed on a subset of donations to provide CMV-seronegative products for specific at-risk patient populations, such as premature infants and transplant recipients.

Written and edited by , founder of Practice Test Geeks, with AI assistance. Exam facts are checked against the official sources linked below. Editorial policy

Sources & references

Exam facts on this page (fees, format, dates, passing scores) are checked against these official sources; the date is our last check. Editorial policy

  1. abpath.org — Exam format, time limit, exam dates, fees, registration, retake policy, score release, test dates, passing score, exam information · verified Nov 2026
  2. home.pearsonvue.com — Test delivery · verified Nov 2026